Bone Marrow Monocyte / Macrophage Derived Activin A Mediates the Osteoclastogenic Effect of IL-3 in Multiple Myeloma

@inproceedings{Silbermann2014BoneMM,
  title={Bone Marrow Monocyte / Macrophage Derived Activin A Mediates the Osteoclastogenic Effect of IL-3 in Multiple Myeloma},
  author={Rebecca Silbermann and Marina Bolzoni and Paola Storti and Daniela Guasco and Sabrina Bonomini and Dan Zhou and Jingwei Wu and Judith L. Anderson and Jolene J. Windle and Franco Aversa and Garson David Roodman and Nicola Giuliani},
  booktitle={Leukemia},
  year={2014}
}
1 Maru Y. Molecular biology of chronic myeloid leukemia. Cancer Sci 2012; 103: 1601–1610. 2 Yeung DT, Hughes TP. Therapeutic targeting of Bcr-Abl: prognostic markers of response and resistance mechanism in chronic myeloid leukaemia. Crit Rev Oncog 2012; 17: 17–30. 3 Giubellino A, Burke Jr TR, Bottaro DP. Grb2 signaling in cell motility and cancer. Expert Opin Ther Targets 2008; 12: 1021–1033. 4 Gishizky ML, Cortez D, Pendergast AM. Mutant forms of growth factor-binding protein-2 reverse Bcr-Abl… CONTINUE READING